$1.62$-1.28 (-44.12%)in 1 year

As on 13 Nov 2026 at 02:29NASDAQ

52 Week Low: $1.3652 Week High: $12.37

Lipocine Share Price Today

Lipocine opened lower at $1.58, compared with its previous close of $1.59. In the last trading session, the stock traded between $1.51 and $1.59. It showed an upward intraday trend.

Return calculator

You have invested

Time Period

An investment of $100 made 5 years ago in Lipocine is now worth

$ 8.05

Resulting in a loss of

$ 91.95 (91.95%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Rating from 1 Analysts

Buy

Hold

100%

Sell

Markets Today

Today's Change

+$0.03 (+1.57%)

Day High

$1.59

Day Low

$1.51

Day Open

$1.58

Prev Close

$1.59

Volume

83,300

1W Return

11.84%

1M Return

-3.47%

3M Return

-23.64%

6M Return

-30.39%

1Y Return

-44.12%

Fundamentals

Market Cap ($ Mn)

PE Ratio

PB Ratio

0.81

PEG Ratio

ROE

-56.01%

ROCE

-60.34%

EPS (TTM)

$-0.08

Investment Returns

1 Week

11.84%

1 Month

-3.47%

3 Months

-23.64%

6 Months

-30.39%

9 Months

-81.48%

Financials

Quarterly

All values in $ Mn

0.1

Mar 25

0.6

Jun 25

0.1

Sep 25

1.1

Dec 25

0.2

Jun 26

2.3

Sep 26

Updates

5Nov

Lipocine Q3 Results: Loss narrows to $(0.08), sales up 1.90K%

Lipocine Inc reported a quarterly loss of $(0.08) per share, beating the $(0.32) estimate. Sales rose 1.90K% YoY to $2.29 million, surpassing the $159.500 thousand forecast. Loss per share narrowed 86.44% from $(0.59) in the same period last year.

7 days ago

4Aug

Lipocine Q2 EPS beats estimate, sales rise 69%

Lipocine delivered better-than-expected Q2 results with EPS of $(0.32) and sales of $190.099K, beating estimates of $(0.43) and $156.500K respectively. Despite the beat, sales fell 69.48% year-over-year from $622.849K, signaling continued top-line weakness even as losses narrowed by 21.95% to $(0.32) per share.

3mo ago

Similar Stocks

Stock	LTP	Change %	Market Cap	PE
V Vertex Pharmaceuticals	$547.03	-0.16%	$1,38,692.89M	31.55
B British American Tobacco	$61.05	+0.38%	$1,31,510.31M	14.39
M Moderna	$248.69	-0.85%	$1,00,625.20M	-
R Regeneron Pharmaceuticals	$959.41	+4.73%	$97,505.80M	19.64
A Argen X SE - ADR	$977.58	+0.62%	$61,476.10M	38.99
O BeOne Medicines - ADR	$419.98	-0.95%	$46,108.31M	65.60
R Revolution Medicines	$180.70	-6.40%	$39,083.96M	-
G Genmab	$53.87	-0.37%	$33,618.11M	26.24
R Royalty Pharma - Class A	$70.01	+0.81%	$31,173.07M	32.37
R Roivant Sciences	$41.85	+1.60%	$30,322.88M	-
I Insmed	$120.75	+1.05%	$26,490.14M	-
I Incyte	$122.27	+1.64%	$24,922.54M	15.85